Navigation and service

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy


New One Health Global Leaders Group on Antimicrobial Resistance launched by WHO, FAO, and OIE

Prof. Lothar H. Wieler, president of the Robert Koch Institute, is part of the new One Health Global Leaders Group on Antimicrobial Resistance launched by WHO, FAO, and OIE. The group consisting of several heads of state, government ministers, CEOs, and leaders of civil society organizations will advocate for urgent action to combat the threat of antimicrobial drug resistance (AMR). Antimicrobial resistance endangers food security, economic development and the world’s ability to fight numerous diseases, including COVID-19. It’s making infections harder to treat and has led to increased health care costs, hospital admissions, treatment failures, severe illnesses and deaths worldwide. Immediate action is needed to avert the severe consequences of antimicrobial resistance on human, animal and environmental health.

The Robert Koch Institute advocates for the One Health approach in tackling the challenge of AMR and is part of numerous research projects and collaborations in this field. Prof. Wieler is veterinarian and microbiologist. As infectious disease expert, his research focuses on zoonotic diseases in a One Health context, particularly on molecular mechanisms enabling zoonotic pathogens to adapt to different hosts and develop resistance to antibiotics. Prof. Wieler works towards building a global, concerted multidisciplinary effort based on One Health to slow the increase in AMR and improve standards of care focusing on preventive measures.

You find more information on the One Health Global Leaders Group on Antimicrobial Resistance:

More information on AMR in general are provided at RKI's website (in German).

Date: 20.11.2020